[1] 吴晓鸥, 张德亭, 罗 涛, 等. 293例妊娠妇女阴道念珠菌病的病原学特征及耐药率分析[J] . 检验医学,2008,23(5): 497-499. [2] 史文娜,孙淑娟. 白念珠菌生物膜的研究[J] . 生命的化学,2008,28(5): 658-661. [3] 王焕丽,陈兴平. 白念珠菌生物膜及其形成的抑制性因素研究进展[J] . 中国真菌学杂志,2009,4(6): 381-384. [4] Cal1ş kan S,Ke?eli Özcan S, C1nar S, et al. In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints [J] . Mikrobiyol Bul,2011,45(4): 697-706. [5] Ciok-Pater E, Biaucha A, Gospodarek E, et al. Susceptibility to antifungal agents of Candida sp. and biofilm formation [J] .Med Dosw Mikrobiol,2011, 63(2): 171-187. [6] Uppuluri P, Srinivasan A, Ramasubramanian A, et al. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion [J] . Antimicrob Agents Chemother, 2011, 55(7): 3591-3593. [7] Iigo M, Pemán J, Del Pozo JL. Antifungal activity against Candida biofilms [J] . Int J Artif Organs,2012, 35(10):780-791. [8] Nett JE, Sanchez H, Cain MT, et al. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan [J] . J Infect Dis,2010,202(1): 171-175. [9] Nett JE, Sanchez H, Cain MT, et al. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation [J] . Eukaryot Cell, 2011,10(12): 1660-1669. [10] Nailis H, Vandenbosch D, Deforce D, et al. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms [J] .Res Microbiol,2010, 161(4): 284-292. [11] Bink A, Govaert G, Vandenbosch D, et al. Transcription factor Efg1 contributes to the tolerance of Candida albicans biofilms against antifungal agents in vitro and in vivo [J] . J Med Microbiol,2012,61(Pt 6): 813-819. [12] Bink A, Vandenbosch D, Coenye T, et al. Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole [J] . Antimicrob Agents Chemother,2011, 55(9): 4033-4037. [13] Cleary IA, MacGregor NB, Saville SP, et al. Investigating the function of Ddr48p in Candida albicans[J] . Eukaryot Cell,2012,11(6): 718-724. [14] Robbins N, Uppuluri P, Nett J, et al. Hsp90 governs dispersion and drug resistance of fungal biofilms [J] .PLoS Pathog,2011, 7(9): e1002257. [15] Shapiro RS, Zaas AK, Betancourt-Quiroz M, et al. The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance [J] . PLoS One,2012, 7(9): e44734. [16] Yi S, Sahni N, Daniels KJ, et al. Alternative mating type configurations (a/α versus a/a or α/α) of Candida albicans result in alternative biofilms regulated by different pathways [J] . PLoS Biol,2011, 9(8): e1001117. [17] Coleman JJ, Okoli I, Tegos GP, et al. Characterization of plant-derived saponin natural products against Candida albicans[J] . ACS Chem Biol,2010, 5(3):321-332. [18] Khan MS, Ahmad I. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans[J] . J Ethnopharmacol,2012, 140(2): 416-423. [19] Khan MS, Ahmad I. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms [J] . J Antimicrob Chemother,2012,67(3): 618-621. [20] Shi W, Chen Z, Chen X, et al. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents [J] .FEMS Yeast Res,2010,10(7): 885-893. [21] Yu LH, Wei X, Ma M, et al. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm [J] . Antimicrob Agents Chemother,2012,56(2): 770-775. [22] Srinivasan A, Uppuluri P, Lopez-Ribot J, et al. Development of a high throughput Candida albicans biofilm chip [J] .PLoS One,2011, 6(4): e19036. |